97 results on '"Panteghini, Mauro"'
Search Results
2. Sources and clinical significance of aspartate aminotransferase increases in COVID-19
3. Is pre-biopsy serum prostate specific antigen retesting always justified? A study of the influence of individual and analytical factors on decision making for biopsy referral
4. Procalcitonin: Between evidence and critical issues
5. Diagnostic value of transferrin
6. Biologic variability of C-reactive protein: Is the available information reliable?
7. Inside ST-elevation myocardial infarction by monitoring concentrations of cardiovascular risk biomarkers in blood
8. Revaluation of biological variation of glycated hemoglobin (HbA1c) using an accurately designed protocol and an assay traceable to the IFCC reference system
9. Improving the laboratory result release process in the light of ISO 15189:2012 standard
10. Biological variability of glycated hemoglobin
11. Assay-related issues in the measurement of cardiac troponins
12. Further improvement of the quality of tube transportation system is needed to prevent ‘seasonal’ pseudohyperkalaemia
13. Trueness verification and traceability assessment of results from commercial systems for measurement of six enzyme activities in serum: An international study in the EC4 framework of the Calibration 2000 project
14. Acute coronary syndrome *: biochemical strategies in the troponin era
15. Recent approaches in standardization of cardiac markers
16. Serum potassium concentrations in COVID-19
17. Highly sensitive troponin T measurement after pneumatic tube transportation: The sample type can make the difference
18. Evaluating and monitoring analytical quality by internal quality control.
19. Defining permissible limits for the combined uncertainty budget in the implementation of metrological traceability.
20. Measurement uncertainty: Friend or foe?
21. Hemoglobin, bilirubin, and lipid interference on Roche Cobas 6000 assays
22. The role of laboratory in ensuring appropriate test requests.
23. Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T.
24. Linking lactate dehydrogenase to the severity of COVID-19 cannot ignore the employed methodology.
25. Harmonization of automated hemolysis index assessment and use: Is it possible?
26. Verification of in vitro medical diagnostics (IVD) metrological traceability: Responsibilities and strategies.
27. Promoting clinical and laboratory interaction by harmonization.
28. Serum albumin: Accuracy and clinical use.
29. Cardiac troponin: a critical review of the case for point-of-care testing in the ED.
30. Traceability as a unique tool to improve standardization in laboratory medicine
31. Comparative study of a new quantitative rapid test with an established ELISA method for faecal calprotectin
32. The new definition of myocardial infarction and the impact of troponin determination on clinical practice
33. Standardization of immunoassays for measurement of myoglobin in serum. Phase I: Evaluation of candidate secondary reference materials
34. Is the accuracy of serum albumin measurements suitable for clinical application of the test?
35. Defining the plasma folate concentration for optimal neural tube defects prevention cannot ignore the impact of the employed methodology.
36. Foreword.
37. Measurement of activin A in acute myocardial infarction: Is there a clinical role?
38. Avoid capture of interfering molecules in cardiac troponin immunoassays: Working in shifts.
39. The role of external quality assessment in the verification of in vitro medical diagnostics in the traceability era.
40. Pre-analytical and analytical aspects affecting clinical reliability of plasma glucose results.
41. Incidence and status of insulin secretion in pregnant women with flat plasma glucose profiles during oral glucose tolerance test.
42. Isoforms of creatine kinase MM and MB in acute myocardial infarction: a clinical evaluation
43. Diagnostic application of CK-MB mass determination
44. Human epididymis protein 4: Factors of variation.
45. Improving clinical laboratory performance through quality indicators.
46. Impact of managing affected results in haemolysed samples of an infant-maternity hospital using an unconventional approach.
47. Reply to "Analytical performance assessment of a novel cartridge-based blood gas analyzer".
48. Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction.
49. Serum human epididymis protein 4 vs. carbohydrate antigen 125 in ovarian cancer follow-up.
50. More about the random uncertainty of photometric determination of hemolysis index on the Abbott Alinity c platform.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.